Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations
Author:
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference130 articles.
1. Practical approaches to immunotherapy in the clinic;Agarwala;Semin. Oncol.,2015
2. Ocular and orbital side-effects of checkpoint inhibitors: a review article;Antoun;Curr. Opin. Oncol.,2016
3. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells;Azuma;Blood,2008
4. Current status and future directions of the immune checkpoint inhibitors ipilimumab, pembrolizumab, and nivolumab in oncology;Barbee;Ann. Pharmacother.,2015
5. Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis;Barroso-Sousa;JAMA Oncol.,2018
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for Resectable Non-small Cell Lung Cancer: a Systematic Review and Network Meta-analysis;Clinical Oncology;2024-02
2. CTLA4 expression profiles and their association with clinical outcomes of breast cancer: a systemic review;Annals of Surgical Treatment and Research;2024
3. Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma;Journal of Experimental & Clinical Cancer Research;2023-11-16
4. PD-1/PD-L1 Blockade Accelerates the Progression of Atherosclerosis in Cancer Patients;Current Problems in Cardiology;2023-03
5. Increased risk of incident diabetes after therapy with immune checkpoint inhibitor compared with conventional chemotherapy: A longitudinal trajectory analysis using a tertiary care hospital database;Metabolism;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3